Close Menu

NEW YORK (360Dx) - BioMérieux announced today it is collaborating with Baxter International to develop technology related to acute kidney injury detection. The firms have agreed to develop biomarkers that will enable rapid identification of AKI and that may also help inform treatment.

Terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.